NCT02871154

Brief Summary

Our and others experience suggest that in some cases delaying oocyte pick up (OPU) for more than 39 hours after hCG injection may be of benefit. We plan to apply this to 20 women in whom less than 20% of oocytes were found suitable for intracytoplasmic sperm injection. The delay will be for up to an interval of 47 hours from hCG to OPU.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2017

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 14, 2016

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 18, 2016

Completed
5 months until next milestone

Study Start

First participant enrolled

January 1, 2017

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

August 18, 2016

Status Verified

August 1, 2016

Enrollment Period

1.9 years

First QC Date

August 14, 2016

Last Update Submit

August 17, 2016

Conditions

Infertility

Outcome Measures

Primary Outcomes (1)

  • Conception

    Two years

Study Arms (1)

Delay

EXPERIMENTAL

Delaying oocyte pick up beyond 39 hours post hCG

Other: Delaying oocyte pick up beyond 39 hours post hCG

Interventions

Delaying oocyte pick up beyond 39 hours post hCGOTHER

Unlike the traditional less-than 39 hours interval from hCG injection to oocyte pick up, we will extend the interval up to 47 hours

Delay

Eligibility Criteria

Age20 Years - 38 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may not qualify if:

  • No previous IVF history

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Infertility

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Study Officials

  • Odeh-L'ya Katz, PhD

    Beruch Padeh Med Ctr Research Authority

    STUDY DIRECTOR

Central Study Contacts

Izhar Ben Shlomo, MD

CONTACT

972-52-6124781ibenshlomo@poria.health.gov.il

Johenny S Younis, MD

CONTACT

972-50-6265477jyounis@poria.health.gov.il

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 14, 2016

First Posted

August 18, 2016

Study Start

January 1, 2017

Primary Completion

December 1, 2018

Study Completion

December 1, 2018

Last Updated

August 18, 2016

Record last verified: 2016-08

Data Sharing

IPD Sharing
Will share

Study results